Literature DB >> 12181444

Activation of phospholipase Cgamma2 by tyrosine phosphorylation.

Fatih Ozdener1, Carol Dangelmaier, Barrie Ashby, Satya P Kunapuli, James L Daniel.   

Abstract

Phospholipase Cgamma2 (PLCgamma2) has been implicated in collagen-induced signal transduction in platelets and antigen-dependent signaling in B-lymphocytes. It has been suggested that tyrosine kinases activate PLCgamma2. We expressed the full-length cDNA for human PLCgamma2 in bacteria and purified the recombinant enzyme. The recombinant enzyme was Ca(2+)-dependent with optimal activity in the range of 1 to 10 microM Ca(2+). In vitro phosphorylation experiments with recombinant PLCgamma2 and recombinant Lck, Fyn, and Lyn tyrosine kinases showed that phosphorylation of PLCgamma2 led to activation of the recombinant enzyme. Using site-directed mutagenesis, we investigated the role of specific tyrosine residues in activation of PLCgamma2. A mutant form of PLCgamma2, in which all three tyrosines at positions 743, 753, and 759 in the SH2-SH3 linker region were replaced by phenylalanines, exhibited decreased Lck-induced phosphorylation and completely abolished the Lck-dependent activation of PLCgamma2. Individual mutations of these tyrosine residues demonstrated that tyrosines 753 and 759, but not 743, were responsible for Lck-induced activation of PLCgamma2. To confirm these results, we procured a phosphospecific antibody to a peptide containing phosphorylated tyrosines corresponding to residues 753 and 759. This antibody recognized phosphorylated wild-type PLCgamma2 on Western blots but did not interact with unphosphorylated PLCgamma2 or with PLCgamma2 containing mutated tyrosine residues at 753 and 759. Using this antibody, we showed in intact platelets that collagen, a PLCgamma2-dependent agonist, induces phosphorylation of PLCgamma2 at Y753 and Y759. These studies demonstrate the importance of these two tyrosine residues in regulating the activity of PLCgamma2.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12181444     DOI: 10.1124/mol.62.3.672

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  25 in total

Review 1.  Phosphorylation state-specific antibodies: applications in investigative and diagnostic pathology.

Authors:  James W Mandell
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

2.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

Review 3.  Pathogenic B-cell receptor signaling in lymphoid malignancies: New insights to improve treatment.

Authors:  Ryan M Young; James D Phelan; Wyndham H Wilson; Louis M Staudt
Journal:  Immunol Rev       Date:  2019-09       Impact factor: 12.988

4.  Hypermorphic mutation of phospholipase C, γ2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation.

Authors:  Ta-Ming Liu; Jennifer A Woyach; Yiming Zhong; Arletta Lozanski; Gerard Lozanski; Shuai Dong; Ethan Strattan; Amy Lehman; Xiaoli Zhang; Jeffrey A Jones; Joseph Flynn; Leslie A Andritsos; Kami Maddocks; Samantha M Jaglowski; Kristie A Blum; John C Byrd; Jason A Dubovsky; Amy J Johnson
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

5.  Role of Src homology domain binding in signaling complexes assembled by the murid γ-herpesvirus M2 protein.

Authors:  Marta Pires de Miranda; Filipa B Lopes; Colin E McVey; Xosé R Bustelo; J Pedro Simas
Journal:  J Biol Chem       Date:  2012-12-20       Impact factor: 5.157

6.  Phosphodiesterase-5 Is Elevated in Failing Single Ventricle Myocardium and Affects Cardiomyocyte Remodeling In Vitro.

Authors:  Anastacia M Garcia; Stephanie J Nakano; Anis Karimpour-Fard; Karin Nunley; Penny Blain-Nelson; Natalie M Stafford; Brian L Stauffer; Carmen C Sucharov; Shelley D Miyamoto
Journal:  Circ Heart Fail       Date:  2018-09       Impact factor: 8.790

Review 7.  Targeting pathological B cell receptor signalling in lymphoid malignancies.

Authors:  Ryan M Young; Louis M Staudt
Journal:  Nat Rev Drug Discov       Date:  2013-03       Impact factor: 84.694

8.  General and versatile autoinhibition of PLC isozymes.

Authors:  Stephanie N Hicks; Mark R Jezyk; Svetlana Gershburg; Jason P Seifert; T Kendall Harden; John Sondek
Journal:  Mol Cell       Date:  2008-08-08       Impact factor: 17.970

9.  Requirements for distinct steps of phospholipase Cgamma2 regulation, membrane-raft-dependent targeting and subsequent enzyme activation in B-cell signalling.

Authors:  Rosie Rodriguez; Miho Matsuda; Amy Storey; Matilda Katan
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes.

Authors:  Nicole Hajicek; Thomas H Charpentier; Jeremy R Rush; T Kendall Harden; John Sondek
Journal:  Biochemistry       Date:  2013-07-09       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.